19,968 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Bought by Strategic Financial Concepts LLC

Strategic Financial Concepts LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 19,968 shares of the company’s stock, valued at approximately $1,312,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in IHE. US Bancorp DE increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 137.0% during the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after acquiring an additional 222 shares during the last quarter. Assetmark Inc. boosted its position in iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after purchasing an additional 216 shares during the period. Union Bancaire Privee UBP SA acquired a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $42,000. Allworth Financial LP raised its position in shares of iShares U.S. Pharmaceuticals ETF by 9.4% in the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after purchasing an additional 159 shares during the period. Finally, EP Wealth Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter worth $157,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

NYSEARCA:IHE opened at $70.05 on Tuesday. The firm has a market capitalization of $707.51 million, a PE ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a 1 year low of $62.67 and a 1 year high of $72.94. The firm’s fifty day simple moving average is $67.38 and its 200 day simple moving average is $69.13.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.